Dietary supplementEFSA
Magnesium bisglycinate 300 mg
300 mg de magnésium élément (80% VNR)
Magnesium contributes to normal functioning of the nervous system and to normal psychological function.
- Evidence level
- Strong evidence
- Active
- Magnésium (bisglycinate)
In which protocols?
This active belongs to the following protocols — dosed, sequenced and tracked in the app.
Read in the Journal
- Magnesium bisglycinate: what it is, and what may lawfully be said about itA chelated form with a reputation for gentleness. What the EU register authorises applies to magnesium, not to bisglycinate — and that distinction changes everything.6 min
- Citrate or bisglycinate: what actually differsTwo forms, two digestive behaviours, one and the same authorised claim. How to choose on criteria that actually exist.5 min
- When should you take magnesium?No European condition of use sets a time. What actually matters: consistency, splitting the dose, and taking it with food.4 min
Regulatory information
Condition of use of the claim
- EFSA ≥ 15 % des VNR (56,25 mg) par portion.(Magnésium)
An authorised claim only holds at its dose. We show it with its condition — without it, the sentence alone means nothing.
Use and warnings
- Daily portion
- 300 mg de magnésium élément (80% VNR)
- Allergens
- none declared
- Do not exceed the recommended daily portion.
- A food supplement does not replace a varied, balanced diet or a healthy lifestyle.
- Keep out of reach of young children.
- Adults only (18+). If pregnant, breastfeeding or on medication, seek advice from a health professional before use.
